Department of Health (Philippines) - All fully vaccinated adults (18 years old and above) are now eligible to receive single-dose booster shots at least three months after the second dose of the
COVID-19 Vaccine Booster Shots (3rd Dose)|Ministry of Health, Labour and Welfare, government of Japan|厚生労働省
AstraZeneca's vaccine dosing 'mistake' led to new dosage finding in mice - Northwestern Now
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses | Nature Medicine
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature Medicine
COVID-19 Vaccine: Booster Dose | Pantai Hospitals - Pantai Malaysia
RACGP - TGA approval clarifies AstraZeneca booster use
Booster Interval Now Three Months For AstraZeneca, Pfizer Recipients - CodeBlue
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
AstraZeneca boss Soriot says do not rush needlessly into COVID booster vaccines -The Telegraph | Reuters
Covid: Double vaccinated can still spread virus at home - BBC News
Frequently asked questions and answers about Moderna COVID-19 vaccine | Bangkok Hospital
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
AstraZeneca's vaccine hopes lie overseas as it runs out of road in UK
COVID-19 Vaccine: Booster Dose
The triumph of the Oxford-AstraZeneca vaccine
AstraZeneca vaccine booster works against Omicron, Oxford lab study finds | Zee Business
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
First U.S. 'Mix and Match' COVID Booster Data Are In | MedPage Today
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ